Response Genetics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Response Genetics generated cash of -$13,599,000, which is more than the previous year. Cash used in financing activities reached the amount of $10,144,000 last year. Net change in cash is therefore -$6,095,000.
Cash Flow
| 2012 | -8.01M | -956.56K | 16.30M |
|---|---|---|---|
| 2013 | -6.48M | -807.87K | 6.40M |
| 2014 | -14.30M | -102.03K | 8.46M |
| 2015 | -13.59M | -2.64M | 10.14M |
RGDXQ Cash Flow Statement (2012 – 2015)
| 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|
Cash at beginning of period | 25.55M | 8.14M | 9.04M | 1.70M |
Operating activities | ||||
Net income | -20.18M | -13.69M | -8.02M | -7.75M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 1.66M | 827.60K | 632.97K | 470.05K |
Stock-based compensation expense | 2.83M | 862.49K | 474.10K | 818.03K |
| Deferred income tax benefit | 2.83M | 862.49K | 474.10K | 818.03K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | -1.66M | -7.42M | -3.76M | 0 |
Inventories | 0 | 0 | 1.00M | 0 |
Accounts payable | 0 | -84.57K | 503.19K | -301.40K |
Cash generated by operating activities | -13.59M | -14.30M | -6.48M | -8.01M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.14M | -104.03K | -607.87K | -956.56K |
Acquisitions Net | -7.49M | 0 | 0 | 0 |
Cash generated by investing activities | -2.64M | -102.03K | -807.87K | -956.56K |
Financing activities | ||||
Common Stock Issued | 10.35M | 0 | 6.57M | 16.45M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | -83K | -168.55K | -188.07K | -147.60K |
Cash used in financing activities | 10.14M | 8.46M | 6.40M | 16.30M |
Net Change In Cash | -6.09M | -5.92M | -892.87K | 7.34M |
Cash at end of period | 19.45M | 2.22M | 8.14M | 9.04M |